Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a poorly treated multifactorial neurodegenerative disease associated with multiple cell types and subcellular organelles. As with other multifactorial diseases, it is likely that drugs will need to target multiple disease processes and cell types to be effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Peter J., Smith, Daniel P., de Giorgio, Alex, Snetkov, Xenia, Almond-Thynne, Joshua, Cronin, Sara, Mead, Richard J., McDermott, Christopher J., Shaw, Pamela J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568794/
https://www.ncbi.nlm.nih.gov/pubmed/37828541
http://dx.doi.org/10.1186/s40035-023-00380-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568794/
https://www.ncbi.nlm.nih.gov/pubmed/37828541
http://dx.doi.org/10.1186/s40035-023-00380-y

Ejemplares similares